- Home
- TKLF vs PMN Comparison
TKLF vs PMN Comparison
Compare TKLF & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- PMN
- Stock Information
- Founded
- TKLF 2006
- PMN 2004
- Country
- TKLF Japan
- PMN Canada
- Employees
- TKLF N/A
- PMN N/A
- Industry
- TKLF Other Specialty Stores
- PMN Pharmaceuticals and Biotechnology
- Sector
- TKLF Consumer Discretionary
- PMN Health Care
- Exchange
- TKLF Nasdaq
- PMN Nasdaq
- Market Cap
- TKLF 16.0M
- PMN 17.0M
- IPO Year
- TKLF 2022
- PMN N/A
- Fundamental
- Price
- TKLF N/A
- PMN $0.45
- Analyst Decision
- TKLF
- PMN Strong Buy
- Analyst Count
- TKLF 0
- PMN 2
- Target Price
- TKLF N/A
- PMN $4.50
- AVG Volume (30 Days)
- TKLF 9.6K
- PMN 50.5K
- Earning Date
- TKLF 07-10-2025
- PMN 08-07-2025
- Dividend Yield
- TKLF N/A
- PMN N/A
- EPS Growth
- TKLF N/A
- PMN N/A
- EPS
- TKLF 1.70
- PMN N/A
- Revenue
- TKLF $219,520,631.00
- PMN N/A
- Revenue This Year
- TKLF N/A
- PMN N/A
- Revenue Next Year
- TKLF N/A
- PMN N/A
- P/E Ratio
- TKLF $2.19
- PMN N/A
- Revenue Growth
- TKLF 32.02
- PMN N/A
- 52 Week Low
- TKLF $2.20
- PMN $0.43
- 52 Week High
- TKLF $8.53
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- TKLF 52.23
- PMN 33.76
- Support Level
- TKLF $3.69
- PMN $0.48
- Resistance Level
- TKLF $3.95
- PMN $0.50
- Average True Range (ATR)
- TKLF 0.18
- PMN 0.03
- MACD
- TKLF 0.01
- PMN -0.00
- Stochastic Oscillator
- TKLF 70.67
- PMN 0.00
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.